Idiopathic Pulmonary Fibrosis: Clinical Pathway
Course of the Month - June 2023
, Best Practices
, Chronic Disease
, Diagnostic Tests
, Focused Exam
, Imaging Selection/Interpretation
, Lung Disease
, Treatment Plan
Course of the Month
Each month, the American Association of Nurse Practitioners® (AANP) will offer a continuing education (CE) activity presented by experts from AANP Communities. For the first month that it is offered, the activity will be FREE and only available to AANP members. After the initial month has passed, the activity will become available to both AANP members and non-members for a fee (AANP members will pay a significantly discounted price). The featured activity will rotate each month, so be sure to complete the activity and earn your CE credit before the month ends to benefit from free access!
Are you interested in this activity but not yet an AANP member? Becoming an AANP member can help you save on the purchase of this course and others — and it will provide you a full year of access to exclusive member benefits. Learn more about AANP membership and consider becoming a member today!
|June 30, 2023 (11:55 p.m. CT)|
|Content Expires:||May 31, 2024 (11:55 p.m. CT)|
CE for this activity will not be available after this date.
|Closed captioning for this activity coming soon!|
This activity is free for AANP members
from 6/1/2023 - 6/30/2023.
Overview Idiopathic pulmonary fibrosis (IPF) is an unpredictable and advanced lung disease with fibrotic changes and an overwhelming disease burden to the patient and their caregivers. IPF is associated with high mortality and morbidity, negatively impacting their health-related quality of life (HRQL). Idiopathic pulmonary fibrosis is a progressive lung disorder with scarring of the lungs from an unknown cause and a poor long-term prognosis (Meyer & Nathan, 2019). Idiopathic Pulmonary Fibrosis (IPF) affects approximately 5 million people worldwide, with an average age of 66 years and an average life span of 3-5 years after confirmed diagnosis (Anderson et al., 2020; Raghu et al., 2018). IPF is an unrelenting ILD associated with a high symptom burden and reported low HRQL (Fenwick & Swan, 2020). IPF has no cure outside a lung transplant; however, supportive care and palliative care, as outlined by the ATS guidelines, ensure sustainable quality of life as the disease progresses (Anderson et al., 2020; Raghu et al., 2018).
- Discuss Idiopathic Pulmonary Fibrosis (IPF).
- Identify risk factors and clinical assessment.
- Discuss workup of IPF as part of PF-ILD.
- Discuss current guidelines and evolving modalities.
- Discuss management of patients with PF-ILD.
- Discuss treatment strategies for patients with PF-ILD.
Temitope Fowora, DNP, CRNP
Disclosure This program was planned in accordance with AANP CE Standards and Policies.
- Temitope Fowora has no personal or financial disclosures to report.
All relevant relationships have been mitigated.DisclaimerIndividuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- Video Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
For questions or more information concerning this CE Center activity, contact AANP CE Center Support at email@example.com.
|1.2 Contact Hour(s) of CE
Additional CE activities of interest
At the Heart of the Matter
Hot Topics In Infectious Disease for the PCP
Pharmacologic Management of Obesity: Improving Health and Reducing Risks in Adolescents and Adults
Understanding Pelvic Organ Prolapse: Evaluation and Management
Head and Neck Cancer Essentials: What NPs Need to Know
Addressing Substance Use Disorders in Primary Care Bundle
Nurse Coaching: The Crucial Tool Missing From the Pain Tool Box
COPD and GOLD Guidelines for the Primary Care NP (N23)
Multiple Sclerosis and Covid-19 Vaccination
Human Trafficking: Nurse Practitioners Leading the Clinical Response
Module 1: Tobacco Cessation
2023 Update on Treatment of Hypertension in Older Adults (N23)